Follow Us
Life Sciences Leaders: Is Your Next Site Selection Decision Future-Ready?
Is Your Next Site Selection Decision Future-Ready?
As the life sciences and medtech sectors evolve at breakneck speed, having the right site selection for your next facility is no longer just about real estate—it’s about aligning with innovation ecosystems, workforce pipelines, and incentive-rich environments.
The Hickey Institute’s 2025 Life Sciences & Medtech Site Selection Strategy Report reveals how emerging hubs like Columbus, Raleigh-Durham, Salt Lake City, and Minneapolis-St. Paul is outpacing legacy markets by offering:
- Workforce-ready communities with specialized training and university partnerships
- Redundant utilities, lab-ready infrastructure, and broadband capacity
- Strategic incentives and public-private partnerships to de-risk investment
- Proximity to AI and tech talent for next-gen drug development and diagnostics
Community Designation Programs
Community designation programs are changing the game:
- The gold standard: Mass BioReady Community Designation – A rating system to determine a municipality’s readiness to host biotechnology facilities, the community’s zoning practices and infrastructure capacity, four tiers from bronze to platinum, helps real estate developers and biotechnology companies find the most favorable destinations to locate, 90 BioReady communities
- New: Ohio’s Life Sciences Ready Community Designation– A rating system modeled after Massachusetts, Ohio’s program has three tiers: Emerging, Advanced, and Premier.
Whether you’re expanding biomanufacturing, launching diagnostics, or scaling AI-driven R&D, the right site selection strategy can unlock millions in incentives and long-term operational success.
Ready to Turn Your Site Selection Into a Strategic Advantage?
Choosing the right location for your life sciences operation is more than a real estate decision—it’s a financial strategy. With the right advisor, you can unlock powerful incentive packages, reduce risk, and position your company for long-term success in a community that’s truly ready to support innovation.
Whether you‘re evaluating BioReady or Life Sciences Ready communities, expanding biomanufacturing, or launching AI-driven diagnostics, we’re here to help you navigate the complexity and negotiate with confidence.
Let’s talk. Schedule a consultation today to discover how our site selection and incentives advisory services can help you exceed your financial goals and accelerate your growth.
Ashmore Consulting is proud to join Pledge 1%, a global movement creating new normal where companies of all sizes integrate giving back into their culture and values. Pledge 1% empowers companies to donate 1% of product, 1% of equity, 1% of profit or 1% of employee time to causes of their choice. Over 1,500 companies in 40 countries have taken the Pledge and committed to give to communities around the world. Ashmore Consulting is excited to join Pledge 1%’s network of founders, entrepreneurs and companies around the globe that have committed to giving back.
